Skip to content

Evaluation of myAirCoach self-management support compared with usual care in asthma: a pragmatic randomized controlled trial

Evaluation of myAirCoach self-management support compared with usual care in asthma: a pragmatic randomized controlled trial - myAirCoach: evaluation campaign

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46602
Enrollment
60
Registered
2017-12-15
Start date
2018-02-16
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma CARA

Interventions

Usual care vs myAirCoach intervention myAirCoach intervention In addition to usual care patients in the myAirCoach group will be provided with self-management support via the myAirCoach system. Thi

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: maximal 60 patients with asthma in NL (and minimal 30 patients in UK) * Age 18+ * Clinician diagnosis of asthma * Asthma treatment step 2-5 - need for regular controller medication (*6 months of the year), this equates to 2 or more ICS prescriptions per year * Poor asthma control (ACQ>0.75) and/or one-or-more exacerbations or hospital visit in the previous year due to asthma * Ownership of a mobile phone compatible with the myAirCoach system (Android operating system)

Exclusion criteria

Exclusion criteria: * Unable to understand Dutch or English, as appropriate

Design outcomes

Primary

MeasureTime frame
Primary objective To assess whether self-management support by the myAirCoach system as an adjunct to usual care improves asthma control in patients with asthma, compared to usual care.

Secondary

MeasureTime frame
Secondary objectives * To determine whether the myAirCoach system improves quality of life, asthma exacerbations and FeNO and lung function level * To determine whether the myAirCoach system improves adherence to medications and asthma self-management * To determine users* acceptance of the myAirCoach system and identify potential issues to the implementation of the system * To assess cost-effectiveness and organisational impact of the myAirCoach system, compared to usual care * To determine whether the Philips Air Purifier improves asthma control, quality of life and exacerbation rate

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)